|
Pharmaceutical Advertising in New Zealand
Simpson Grierson Partners Neil Cameron and Peter Stubbs have produced a guide for the ICLG. It is practical insight to cross-border Pharmaceutical Advertising work, that explores the principle laws and codes of practice governing the advertising of medicine and medical devices. Contact Neil Cameron on +64-9-977-5050 or Peter Stubbs on +64-9-977-5010 for further information.
"This article first appeared in the fourth edition of The International Comparative Legal Guide to: Pharmaceutical Advertising; published by Global Legal Group Ltd, London (www.iclg.co.uk)" .
> Download PDF
Commerce Commission Investigations
Growing government regulation and an increasingly litigious environment were flagged as top concerns in Simpson Grierson's latest research. The guide presents real life 'survival' scenarios such as what to do when the Commission calls you and tips for a Commerce Commission interview. To receive a copy of the guide, please contact Simpson Grierson Partner Anne Callinan on +64-9-977-5031.
Commerce Commission Investigations under the CCCFA
Taking a closer look at the Credit Contracts and Consumer Finance Act 2003 (CCCFA), the guide is a useful introduction to the investigative powers and role of the Commerce Commission under the CCCFA. To receive a copy of the guide, please contact Simpson Grierson Partner Anne Callinan on +64-9-977-5031.
Doing Business in NZ
Simpson Grierson has produced a practical handbook that looks at trade and enterprise in New Zealand, provides key facts about New Zealand and highlights areas of New Zealand law which may affect you while doing business in New Zealand.
> View the PDF's
Prime Assets
Each week, Simpson Grierson's Commercial Property Group answers a weekly Q&A column in The New Zealand Herald entitled 'Prime Assets'. Each Q&A is a practical, no-nonsense look at everyday commercial property issues being faced in the New Zealand market.
Sales & Marketing Checklists
How can you protect your Intellectual Property?
Private Equity & Venture Capital
|
